PENNANT GROUP INC

Insider Trading & Executive Data

PNTG
NASDAQ
Healthcare
Medical Care Facilities

Start Free Trial

Get the full insider signal for PNTG

43 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.

Trade-level insider transactions with filing links, transaction codes, and footnotes
Executive compensation trends by role with year-over-year comparisons
Institutional ownership shifts by quarter with top-holder concentration data
Form 144 and Form 8-K monitoring with AI analysis and CSV export tools

Insider Activity Summary

Insider Trades (1Y)
43
0 in last 30 days
Buy / Sell (1Y)
35/8
Acquisitions / Dispositions
Unique Insiders (1Y)
12
Active in past year
Insider Positions
17
Current holdings
Position Status
13/4
Active / Exited
Institutional Holders
188
Latest quarter
Board Members
21

Compensation & Governance

Avg Total Compensation
$1.1M
Latest year: 2024
Executives Covered
9
Comp records available
Form 8-K Events (1Y)
0
Personnel Changes (1Y)
0
Bonus Plan Events (1Y)
0
Organization Changes (1Y)
0
Board Appointments (1Y)
0
Board Departures (1Y)
0

Restricted Sales

Form 144 Filings (1Y)
4
Form 144 Insiders (1Y)
2
Planned Sale Shares (1Y)
20.6K
Planned Sale Value (1Y)
$555290.44
Price
$33.64
Market Cap
$1.2B
Volume
7,888.166
EPS
$0.84
Revenue
$947.7M
Employees
7.0K
About PENNANT GROUP INC

Company Overview

Pennant Group, Inc. is a vertically integrated provider of post-acute care and senior living services operating 123 home health and hospice agencies and 57 senior living communities across 13 states. The business is heavily Medicare/Medicaid-exposed (roughly 48% Medicare, 13% Medicaid) and generated ~75% of 2024 revenue from home health and hospice, with the remainder from senior living. Management runs a decentralized, cluster-based operating model supported by a central Service Center, and pursues organic census growth plus disciplined acquisitions while highlighting data analytics and strong CMS quality scores as competitive advantages. Key operational pressures include labor/wage inflation (payroll ~67.7% of expenses), reimbursement/regulatory changes (PDGM, HHVBP, hospice caps), and integration risk from frequent acquisitions.

Executive Compensation Practices

Given Pennant’s growth-by-acquisition model and use of non‑GAAP metrics, compensation for executives is likely tied to volume and margin metrics such as admissions, occupancy, revenue per episode/unit, Adjusted EBITDA and Adjusted EBITDAR rather than GAAP net income alone. Short‑term incentives are likely driven by organic census growth, senior living pricing/occupancy, and near‑term margin improvement, while long‑term equity awards probably emphasize successful integration of acquisitions, sustained quality scores (CMS ratings) and total shareholder return. The payroll‑heavy cost structure and liquidity constraints (recent $118M equity raise, $250M revolver) make cash conservation a likely factor—expect a mix favoring equity or performance‑based awards over large cash payouts, and explicit clawbacks or forfeiture provisions tied to regulatory/audit findings. Local cluster leaders may have compensation plans tied to local operating metrics (census, local margins), while corporate leadership’s incentives will focus on consolidated adjusted EBITDA/EBITDAR and covenant compliance.

Insider Trading Considerations

Material drivers for insider trading activity at a Healthcare / Medical Care Facilities company like Pennant include regulatory rule changes (CMS payment rules, hospice cap updates), quarterly operational cadence (admissions, occupancy, revenue per unit), and acquisition announcements or integration updates that change forward earnings visibility. Because management uses non‑GAAP measures to evaluate performance and value acquisitions, option grants and performance awards tied to those measures can create predictable vesting events and potential trading around targets—watch for sales after equity raises or option exercises. Regulatory and enforcement risk (Medicare/Medicaid audits, hospice cap exposure, fraud-and-abuse scrutiny) creates frequent blackout/window timing for insiders and increases the importance of 10b5‑1 plans; investors should monitor Form 4 filings for patterns around CMS rule publication dates, earnings releases, and major acquisition closings.

Unlock Full Insider Trading Data
Get complete access to insider trades, executive compensation, institutional holdings, and AI-powered analysis for PENNANT GROUP INC and thousands of other companies.
Individual insider trade details with transaction history
Executive compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Form 144 restricted sale filings with details
Form 8-K governance events and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
No credit card required
Cancel anytime